ATRX and colorectal carcinoma: ARID1A, KMT2C, RSF1, CHD9, PBRM1, and ATRX were the most mutated genes in the TCGA cohort, accounting for approximately 75% of the epigenetic-related gene-mutated MSS-CRC patients.